Comparing Alpha vs Beta Radiation Range & Energy to Tumor Biology to Maximize Disease Coveragee

4:30 pm - Wednesday 24th February 2027

  • Assessing tumor size, architecture & target heterogeneity to determine whether short-range alpha or longer-range beta irradiation provides better disease coverage
  • Leveraging beta crossfire or high-LET alpha irradiation to overcome differences in target density & spatial distribution
  • Matching radionuclide half-life & dose rate to vector PK and tumor residence to ensure radiation is delivered while the targeting agent remains at the tumor

Speakers:

Chief Scientific Officer
dGenThera